Table 4 Longitudinal analysis of factors to explain the decline in eGFRa
Objective variable | ⊿eGFR in 10 years | ||||||||
|---|---|---|---|---|---|---|---|---|---|
All | Younger age | Older age | |||||||
β (SE) | t value | p value | β (SE) | t value | p value | β (SE) | t value | p value | |
BMI | −0.01 (0.11) | −0.08 | 0.94 | −0.17 (0.17) | −0.98 | 0.32 | 0.01 (0.15) | 0.05 | 0.96 |
MBP | −0.06 (0.03) | −1.97 | < 0.05 | −0.06 (0.05) | −1.26 | 0.20 | −0.05 (0.04) | −1.36 | 0.18 |
UA | 1.17 (0.28) | 4.12 | < 0.05 | 1.69 (0.44) | 3.84 | < 0.05 | 0.59 (0.37) | 1.60 | 0.11 |
HbA1c | −2.30 (0.57) | −4.07 | < 0.05 | 2.22 (1.77) | 1.25 | 0.21 | −2.83 (0.60) | −4.70 | < 0.05 |
rs35767 polymorphism | |||||||||
 CC | Ref | Ref | Ref | ||||||
 TC | −0.19 (0.67) | −0.28 | 0.78 | −0.99 (0.96) | −1.03 | 0.31 | 0.71 (0.93) | 0.77 | 0.44 |
 TT | −2.42 (1.06) | −2.28 | < 0.05 | −3.90 (1.53) | −2.55 | < 0.05 | −1.02 (1.47) | −0.70 | 0.49 |